| # | Country | Total Patents | |
|---|---|---|---|
| #1 | China | 9 | |
| #2 | WIPO (World Intellectual Property Organization) | 9 | |
| #3 | EPO (European Patent Office) | 7 | |
| #4 | United States | 6 | |
| #5 | Canada | 4 | |
| #6 | Republic of Korea | 4 | |
| #7 | Israel | 3 | |
| #8 | Brazil | 2 | |
| #9 | Singapore | 2 | |
| #10 | Australia | 1 | |
| #11 | Mexico | 1 |
| # | Industry | |
|---|---|---|
| #1 | Biotechnology | |
| #2 | Pharmaceuticals | |
| #3 | Measurement |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Therapeutic chemical compounds | |
| #3 | Medical preparations | |
| #4 | Microorganisms | |
| #5 | Analysing materials |
| # | Name | Total Patents |
|---|---|---|
| #1 | Meyer Sebastian | 36 |
| #2 | Gunde Tea | 31 |
| #3 | Urech David | 16 |
| #4 | Hess Christian | 15 |
| #5 | Simonin Alexandre | 10 |
| #6 | Brock Matthias | 6 |
| #7 | Sebastian Meyer | 5 |
| #8 | Diem Dania | 3 |
| #9 | Tea Gunde | 3 |
| #10 | Bieri Tessa | 2 |
| Publication | Filing date | Title |
|---|---|---|
| WO2018224439A1 | Novel anti-hsa antibodies | |
| WO2018224441A1 | Novel anti-cd3 antibodies | |
| EP3470428A1 | Antibodies targeting cd137 and methods of use thereof | |
| EP3470429A1 | Antibodies targeting pdl1 and methods of use thereof | |
| EP3459968A1 | Novel stable antibody variable domain framework combinations | |
| EP3430042A1 | Anti-tnf -antibodies and functional fragments thereof | |
| EP3430041A1 | Anti-tnfalpha-antibodies and functional fragments thereof | |
| SG11201808041UA | ANTI-TNFa-ANTIBODIES AND FUNCTIONAL FRAGMENTS THEREOF |